3644 results for «2827»
3644 results
Controversies and conversations in TAVI
21 May 2026 – From EuroPCR 2026
This session addresses key controversies and discussions in transcatheter aortic valve implantation (TAVI), including the role of invasive coronary angiography prior to TAVI, use of cangrelor during combined TAVI and high-risk PCI, and discrepancies in aortic valve stenosis assessment methods. Additional topics cover operator models, valve...
New data on intracoronary imaging-guided interventions
21 May 2026 – From EuroPCR 2026
This session presents new data on intracoronary imaging-guided interventions, comparing outcomes of angiography-derived FFR and IVUS-guided PCI over two years, as well as OCT versus IVUS for intermediate left main stenosis. It further evaluates high-risk non-culprit lesions post-myocardial infarction, the role of coronary lipid burden in...
All you need to know of DAPT in ACS
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of dual antiplatelet therapy (DAPT) in acute coronary syndrome (ACS), focusing on strategies for safe de-escalation and P2Y12 inhibitor monotherapy to reduce bleeding risk without compromising ischemic protection. It also covers optimizing antithrombotic therapy in patients on oral anticoagulation and...
A series of complex real-word challenges STEMI treatment from very different countries
21 May 2026 – From EuroPCR 2026
This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...
Bifurcation and heavily calcified lesions
21 May 2026 – From EuroPCR 2026
This session addresses the evaluation and treatment of bifurcation and heavily calcified coronary lesions. It includes case-based discussions on complex left main PCI and the use of drug-coated balloons (DCB) for bifurcation lesions and in-stent restenosis, providing evidence-based approaches to optimize outcomes in these challenging lesion...
Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases
21 May 2026 – From EuroPCR 2026
This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...
Case-based challenges and dilemmas in multivessel PCI
21 May 2026 – From EuroPCR 2026
This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...
SCAD, PCI specific strategies
21 May 2026 – From EuroPCR 2026
This session focuses on specific percutaneous coronary intervention strategies for spontaneous coronary artery dissection (SCAD) and related coronary anomalies. It covers clinical and therapeutic aspects of adult coronary aneurysms, woven coronary anomalies, innovative stent optimization techniques, microvascular dysfunction in takotsubo syndrome, and real-world management of SCAD...
Complication management after tricuspid valve interventions
21 May 2026 – From EuroPCR 2026
This session reviews complication management following tricuspid valve interventions, highlighting practical approaches to unexpected procedural events. Topics include management of TricValve pop-up complications, Evoque device challenges, acute leaflet thrombosis emergencies, and bailout strategies for single leaflet detachment in tricuspid transcatheter edge-to-edge repair (TEER).
Devices and strategies in calcified lesions
21 May 2026 – From EuroPCR 2026
Explore advanced devices and techniques for treating calcified coronary lesions in this session. Discussions include the use of Eximer laser coronary atherectomy, novel cutting balloons, outcomes of rotational atherectomy in tortuous vessels, atherectomy combined with drug-coated balloon therapy, and calcium fracture patterns following Shockwave intravascular lithotripsy.
Addressing difficult anatomy in STEMI patients
21 May 2026 – From EuroPCR 2026
This session addresses the challenges of managing difficult coronary anatomy in STEMI patients through a series of complex case studies. Topics include management of aneurysms, rare aorto-ostial lesions, thrombosis interplay, PPCI in dextrocardia situs inversus, and hybrid PCI approaches for multifaceted coronary issues.
FFR and non-hyperaemic pressure ratios
20 May 2026 – From EuroPCR 2026
This session presents contemporary clinical applications of fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR), highlighting real-world impacts of physiology microcatheter-based indices, the interplay between epicardial stenosis and microvascular resistance, post-PCI hyperemia effects on iFR, and machine-learning driven outcome predictions.
Other right-sided and tricuspid valve interventions
20 May 2026 – From EuroPCR 2026
This session focuses on right-sided heart valve interventions, particularly targeting tricuspid valve disease. Topics include clinical outcomes in atrial functional tricuspid regurgitation, management in the context of left-sided valvular disease, treatment approaches for tricuspid valve endocarditis, and advances in transcatheter therapies and device placements.
Insights from real world TAVI practice
20 May 2026 – From EuroPCR 2026
This session presents comprehensive insights from real-world transcatheter aortic valve implantation (TAVI) practice, including sex differences in coronary assessment, the impact of general anesthesia on aortic valve gradients, early rehospitalisation rates, and the management of TAVI in patients with prior hip arthroplasty. Additionally, it explores multinational...
When transcatheter LAA closure becomes challenging
20 May 2026 – From EuroPCR 2026
This session addresses the technical and clinical challenges encountered during transcatheter left atrial appendage (LAA) closure, including management of peri-device leaks, alternative access routes like transhepatic approaches, complications following surgical closures, and rare procedural adversities such as accidental aortic puncture.
Interventions for heart failure: shock and beyond
20 May 2026 – From EuroPCR 2026
Focused on interventions for heart failure, this session presents data on mitral regurgitation post-alcohol septal ablation, outcomes from high-risk PCI supported by Impella CP, evolving trends in ECMO utilization for cardiogenic shock, and six-month patient outcomes guided by shock team management strategies.
Best cases in stable CAD
20 May 2026 – From EuroPCR 2026
This session showcases exemplary cases in stable coronary artery disease, emphasizing complex diagnostic and therapeutic challenges such as ambiguous angiographic findings, refractory vasospastic angina, catastrophic no-reflow phenomena, and the application of physiology-guided PCI and coronary sinus reducers.
Complex left main patients and PCI
20 May 2026 – From EuroPCR 2026
This session addressed the complexities of left main PCI, focusing on managing hemodynamic uncertainty in high-risk interventions, advanced techniques such as ultra-low contrast rota-tripsy PCI, precise stent positioning, and pragmatic approaches to CHIP cases, emphasizing contrast-sparing strategies and best practice balancing.
New data in DCB outcomes
20 May 2026 – From EuroPCR 2026
Explore emerging evidence on drug-coated balloon (DCB) outcomes, featuring intravascular lithotripsy combined with DCB in calcified small vessels, OCT-guided PCI registries, predictors of angiographic success post-sirolimus-coated balloon angioplasty, and clinical impact in multivessel coronary artery disease management.
AI adoption in the cathlab of tomorrow - Intravascular imaging applications
20 May 2026 – From EuroPCR 2026
This session examines the integration of artificial intelligence in intravascular imaging within the cath lab, identifying unmet needs in OCT interpretation, exploring AI's role in enhancing procedural decision-making and trust, and discussing barriers to implementation such as prediction reliability and clinical actionability.
